Lamotrigine 25 mg | ≥98% LKT Laboratories, Inc. R-type Ca2+ and voltage-gated Na+ channel blocker. More Information Supplier Page × Lamotrigine
Terbutaline 5 g | ≥98% LKT Laboratories, Inc. β2-adrenergic agonist, potential ENaC activator. More Information Supplier Page × Terbutaline
Terbutaline 1 g | ≥98% LKT Laboratories, Inc. β2-adrenergic agonist, potential ENaC activator. More Information Supplier Page × Terbutaline
Lansoprazole 1 g | ≥98% LKT Laboratories, Inc. H+/K+ ATPase inhibitor. More Information Supplier Page × Lansoprazole
Terbinafine Hydrochloride 1 g | ≥98% LKT Laboratories, Inc. Allylamine; squalene oxidase and KSR1 inhibitor. More Information Supplier Page × Terbinafine Hydrochloride
Terbinafine Hydrochloride 5 g | ≥98% LKT Laboratories, Inc. Allylamine; squalene oxidase and KSR1 inhibitor. More Information Supplier Page × Terbinafine Hydrochloride
Levonorgestrel 500 mg | ≥98% LKT Laboratories, Inc. Synthetic progestogen; contraceptive. More Information Supplier Page × Levonorgestrel
Levonorgestrel 100 mg | ≥98% LKT Laboratories, Inc. Synthetic progestogen; contraceptive. More Information Supplier Page × Levonorgestrel
Terazosin Hydrochloride Dihydrate 1 g | ≥98% LKT Laboratories, Inc. Quinazoline; α1-adrenergic antagonist. More Information Supplier Page × Terazosin Hydrochloride Dihydrate
Terazosin Hydrochloride Dihydrate 250 mg | ≥98% LKT Laboratories, Inc. Quinazoline; α1-adrenergic antagonist. More Information Supplier Page × Terazosin Hydrochloride Dihydrate
